For the detection of neutralizing antibodies of SARS-CoV-2, sELISA kits offer a convenient alternative to neutralization tests, as they can be used under standard laboratory safety conditions. A recent study compared two commercially available kits and tested their specificity and selectivity.

The Science Behind a New ELISA for COVID-19 Seroconversion Detection

The recent and rapid spread of the novel coronavirus, SARS-CoV-2, has necessitated the development of new assays that are capable of detecting the presence of this virus in patient samples or evidence of recent infection.

FRET Substrates for COVID-19 Vaccine Development

AAT Bioquest offers a variety of dark-FRET peptide substrates and fluorogenic substrates which can be effectively used to screen for inhibitors of coronavirus proteases, papain-like proteases and more.

Raw Materials for COVID-19 IgG/IgM Rapid Test Development

In the current state of the COVID-19 pandemic, there is high demand for rapid tests using a lateral flow technique for the detection of IgG and IgM antibodies against SARS-CoV-2.

Using Existing Therapeutics Against COVID-19

Currently, there are no approved drugs to treat the SARS-CoV-2 infection that causes COVID-19. Existing drugs are being examined for strategies to treat the disease.

RT-qPCR Detection Kit for SARS-CoV-2

We are pleased to introduce a new kit from Assay Genie for robust and reproducible one-step coronavirus detection using real time RT-qPCR.

ACE2 - The SARS-CoV-2 Receptor

The novel coronavirus SARS-CoV-2, which causes COVID-19, shares 79.5% sequence identity with the virus responsible for SARS. Both viruses use the same receptor ACE2 for mediating viral entry into host cells.

SARS-Coronavirus Antibodies

Following the recent pandemic of COVID-19 we are highlighting antibodies against the related SARS-Coronavirus.